Drug Type Recombinant polypeptide |
Synonyms NU 206, NU-206, NU206 + [2] |
Target |
Action modulators |
Mechanism DKK1 modulators(Dickkopf-related protein 1 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bone Diseases | Phase 1 | China | - | |
Bone Diseases | Phase 1 | Australia | - | - |
Bone Diseases | Phase 1 | - | - | |
Inflammatory Bowel Diseases | Phase 1 | China | - | |
Inflammatory Bowel Diseases | Phase 1 | Australia | - | - |
Inflammatory Bowel Diseases | Phase 1 | - | - | |
Mucositis | Phase 1 | China | - | |
Mucositis | Phase 1 | Australia | - | - |
Mucositis | Phase 1 | - | - | |
Wounds and Injuries | Phase 1 | Australia | - | - |